A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : VAP / ventilator-associated pneumonia

[Related PubMed/MEDLINE]
Total Number of Papers: 2650
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   VAP  (>> Co-occurring Abbreviation)
Long Form:   ventilator-associated pneumonia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 "Risk factors for ventilator-associated pneumonia following cardiac surgery: case-control study". ---
2020 A clinical trial of silver-coated and tapered cuff plus supraglottic suctioning endotracheal tubes in preventing ventilator-associated pneumonia. ETT, ICU
2020 A new scoring system for early diagnosis of ventilator-associated pneumonia: LUPPIS. CPIS, LUPPIS, PTX-3
2020 A review of health economic models exploring and evaluating treatment and management of Hospital-Acquired Pneumonia (HAP) and Ventilator Associated pneumonia (VAP). HAP
2020 A scope at antifouling strategies to prevent catheter-associated infections. CAUTIs, CLABSIs, HAIs, PEG, SLIPS
2020 Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP). ---
2020 Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia. CPIS, VAT
2020 Accuracy of ventilator-associated events for the diagnosis of ventilator-associated lower respiratory tract infections. VA-LRTI, VAE, VAT
2020 Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018. CRE, HAP
10  2020 Additional medical costs associated with ventilator-associated pneumonia in an intensive care unit in Japan. USD
11  2020 An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia. ESBL, HAP, MDR
12  2020 Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patients. ICU
13  2020 Antibiotic resistance and sensitivity pattern of Metallo-beta-Lactamase Producing Gram-Negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. ICU, MBL
14  2020 Assessment of the Clinical Pulmonary Infection Scores for prediction of ventilator associated pneumonia in patients with out of hospital cardiac arrest. CPIS, ICU, OHCA
15  2020 Assessment of the sedative effects of dexmedetomidine and propofol treatment in patients undergoing mechanical ventilation in the ICU and relationship between treatment and occurrence of ventilator-associated pneumonia and detection of pathogenic bacteria. ICU, ROC
16  2020 Assessment of ventilator-associated pneumonia by combining 8-isoprostane and nitric oxide levels in exhaled breath condensate with the clinical pulmonary infection score. AUC, CPIS, EBC, LIS, NO, ROC
17  2020 Association between sepsis at ICU admission and mortality in patients with ICU-acquired pneumonia: An infectious second-hit model. HR, ICUAP
18  2020 Associationbetween hyperoxia and mortality in severely burned patients. TBSA
19  2020 Avoiding ventilator-associated pneumonia: Curcumin-functionalized endotracheal tube and photodynamic action. ETT, PDI
20  2020 Biofilm formation on three different endotracheal tubes: a prospective clinical trial. ETTs, PVC
21  2020 Changes in immune indicators and bacteriologic profile were associated with patients with ventilator-associated pneumonia. ---
22  2020 Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018. CLABSI, DDD, GNB, HAIs, ICU, MDR, UTI, VRE
23  2020 Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. HAP, MDR
24  2020 Clinical effectiveness of high dose versus standard dose of meropenem in ventilator-associated pneumonia caused by multidrug-resistant bacteria: a randomized single-blind clinical trial. CPIS, SOFA
25  2020 Clinical impact of lung ultrasound monitoring for diagnosis of ventilator associated pneumonia: A diagnostic randomized controlled trial. CXR, VFD
26  2020 Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis. BSI, CI, MDRB, OR, TIG
27  2020 Combined Use of Three Machine Learning Modeling Methods to Develop a Ten-Gene Signature for the Diagnosis of Ventilator-Associated Pneumonia. Arg1, AUC, CFD, DEGs, DUSP2, GEO, GO, Hp, IL18R1, KEGG, LAMB3, LASSO, MLP, MMP-8, NAIP, PHLDA2, PLAU, ROC
28  2020 Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study. CPIS
29  2020 Consecutive outbreaks of Burkholderia cepacia complex caused by intrinsically contaminated chlorhexidine mouthwashes. Bcc, ERIC-PCR, ICU
30  2020 Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam. cIAI, cUTI, HAP, PK
31  2020 Contrasting effects of linezolid on healthy and dysfunctional human neutrophils: reducing C5a-induced injury. MRSA
32  2020 Cost-Effective Home Mechanical Ventilation in Neurosurgery Patients: Case Series of Three Patients. HMV, INR
33  2020 Crosstalk between brain, lung and heart in critical care. ARDS, NPE
34  2020 Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients. VA-LRTI
35  2020 Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. BAL, CI, ETA, PSB
36  2020 Diagnosis of ventilator-associated pneumonia using electronic nose sensor array signals: solutions to improve the application of machine learning in respiratory research. ---
37  2020 Diagnostic value of pentraxin 3 in respiratory tract infections: A meta-analysis. BALF, LR, SROC
38  2020 Does lack of thoracic trauma attenuate the severity of pulmonary failure? An 8-year analysis of critically injured patients. ARDS, ICU
39  2020 Economic and Epidemiological Impact of an Improvement Plan for the Decrease of Ventilator-Associated Pneumonia in a Tertiary Hospital in Mexico. CQIP
40  2020 Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol. CDAD, ICU
41  2020 Effect of gastric residual volume monitoring on incidence of ventilator-associated pneumonia in mechanically ventilated patients admitted to intensive care unit. GRV
42  2020 Effect of rs4719839 polymorphism on risk of ventilator-associated pneumonia, expression of microRNA-148 and autophagy-related 16-like 1 (ATG16L1). ATG16L1, ATG16L1, PBMCs, SNP
43  2020 Effects of a national quality improvement program on ICUs in China: a controlled pre-post cohort study in 586 hospitals. DVT, QI
44  2020 Enhanced oral hygiene interventions as a risk mitigation strategy for the prevention of non-ventilator-associated pneumonia: a systematic review and meta-analysis. NVAP, OCIs
45  2020 Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia. GNB, HAP, MDR, US, XDR
46  2020 Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia. ELF
47  2020 Evaluation of the Novel Antimicrobial BCP3 in a Coating for Endotracheal Tubes. ETT
48  2020 Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients. AKI, TICU
49  2020 Genomic features, whole-genome phylogenetic and comparative genomic analysis of extreme-drug-resistant ventilator-associated-pneumonia Acinetobacter baumannii strain in a Vietnam hospital. COGs
50  2020 Healthcare-associated Infection in Intensive Care Units: Overall Analysis of Patient Criticality by Acute Physiology and Chronic Health Evaluation IV Scoring and Pathogenic Characteristics. APACHE, HAIs, ICUs
51  2020 Healthcare-associated infection prevention and control management in a tertiary hospital and an overall evaluation. CAUTI, HAI, HCWs, MDRO, SSI
52  2020 High tidal volume ventilation is associated with ventilator-associated pneumonia in acute cervical spinal cord injury. HVtV, SCI
53  2020 High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit. A. baumannii, HD, HR, SD, TGC
54  2020 Hospital admissions for community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in COPD patients in Spain (2016-2017). CAP, CAP, IHM, IRR, NV-HAP
55  2020 Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention. HAP
56  2020 Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update. HAP
57  2020 Impact of Chronic Obstructive Pulmonary Disease on Incidence, Microbiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections. COPD, ICU, MV, VA-LRTI, VAT
58  2020 Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae. CI, HR, KPC
59  2020 Impact of obstructive sleep apnea on the obesity paradox in critically ill patients. ICU, OSA
60  2020 Impact of Oral Care and Antisepsis on the Prevalence of Ventilator-Associated Pneumonia. ICU
61  2020 Implementation and evaluation of a care bundle for prevention of non-ventilator-associated hospital-acquired pneumonia (nvHAP) - a mixed-methods study protocol for a hybrid type 2 effectiveness-implementation trial. HAP, nvHAP, nvHAP, UHZ
62  2020 Implementation of the TaperGuard™ endotracheal tube in an unselected surgical population to reduce postoperative pneumonia. ETT, OR
63  2020 In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial. NP
64  2020 Incidence and outcomes of hospitalization for community-acquired, ventilator-associated and non-ventilator hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain. CAP, IHM, IRR, NV-HAP, T2DM
65  2020 Incidence and risk factors of non-device-associated pneumonia in an acute-care hospital. CI, HR, ND pneumonia
66  2020 Incidence, Risk Factors, and Effects on Outcome of Ventilator-Associated Pneumonia in Patients With Traumatic Brain Injury: Analysis of a Large, Multicenter, Prospective, Observational Longitudinal Study. HR, IQR, LOS, TBI
67  2020 Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis. CI, OR, TBI
68  2020 Infection prevention practices in the Netherlands: results from a National Survey. CAUTI, CDI, CLABSI, TRIP
69  2020 Intra-Abdominal Hypertension is a Risk Factor for Increased VAP Incidence: A Prospective Cohort Study in the ICU of a Tertiary Hospital. IAH
70  2020 Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates. ASZ, MDR-GNB
71  2020 Intubation in burns patients: a 5-year review of the Manchester regional burns centre experience. ABA
72  2020 Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? HAP
73  2020 Knowledge, attitude and oral care practices for preventing ventilator-associated pneumonia among critical care nurses - A questionnaire study. ICU
74  2020 Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study. COVID-19, HDL-C, HDLs, LDL-C, LDLs
75  2020 Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome. ARDS, ICU, VA-LRTIs, VAT
76  2020 Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS. ICUs, LUSS
77  2020 Making Ventilator Associated Pneumonia Rate a Meaningful Quality Marker. ISS, PHAR
78  2020 Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals. ETA, ICU, MDR
79  2020 Mild and Moderate Traumatic Brain Injury and Gender-Based Critical Care Outcomes. AIS, EDH, GCS, ICU-LOS, ISS, TBI
80  2020 Molecular characterization of a multidrug-resistant/pandrug-resistant nosocomial polymicrobial infection with Klebsiella pneumoniae, Providencia rettgeri, and Acinetobacter baumannii from Rural Maharashtra, India. ---
81  2020 Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-associated Pneumonia. BAL, ETA
82  2020 Mortality from acinetobacter infections as compared to other infections among critically ill patients in South India: A prospective cohort study. AR-HAI, CI, CLABSIs, HAIs, NAR-HAI, OR
83  2020 Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. CAP, HAP, rm-PCR
84  2020 Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP). BALF, P. aeruginosa, PA-MCDA
85  2020 Near-zero ventilator-associated pneumonia rates after implementation of a multimodal preventive strategy in a Mexican hospital. ---
86  2020 Occurrence of ventilator associated pneumonia using a tracheostomy tube with subglottic secretion drainage. ICUs, MV
87  2020 Oropharyngeal colostrum therapy reduces the incidence of ventilator-associated pneumonia in very low birth weight infants: a systematic review and meta-analysis. BPD, CI, NEC, OC, OR, RCTs, VLBWs
88  2020 Pathogenesis-Targeted Preventive Strategies for Multidrug Resistant Ventilator-Associated Pneumonia: A Narrative Review. CHX, ETTs, ICU, MDR, SOD, SSD
89  2020 PCR coupled to electrospray ionization mass spectrometry for microbiological diagnosis and surveillance of ventilator-associated pneumonia. ---
90  2020 Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model. ELF, PK/PD
91  2020 Photodynamic Activity on Biofilm in Endotracheal Tubes of Patients Admitted to an Intensive Care Unit. aPDT, ETT, MB
92  2020 Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance. ---
93  2020 Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials. OR
94  2020 Procalcitonin in the Assessment of Ventilator Associated Pneumonia: A Systematic Review. ---
95  2020 Pulmonary contusions in patients with rib fractures: The need to better classify a common injury. ---
96  2020 Race Impacts Outcomes of Patients With Firearm Injuries. ADRS, AMD, AOR
97  2020 Rapid syndromic molecular testing in pneumonia: The current landscape and future potential. CAP, HAP
98  2020 Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome. ---
99  2020 Reducing Three Infections Across Cardiac Surgery Programs: A Multisite Cross-Unit Collaboration. CLABSI, SSI
100  2020 Rib fixation in geriatric trauma: Mortality benefits for the most vulnerable patients. ICU, LOS, SSRF